成人直播

Saturday, April 18, 2026
UofL student Sam Kessler using the water testing tool
UofL students invent new test for water pollution
A team of University of Louisville undergraduate students has invented a new tool for monitoring E.coli bacteria in water sources that could be more...
Jun Yan, center, leads research to better understand immune dysregulation leading to acute respiratory distress in COVID-19 and other conditions. Yan and colleagues, including Anne Geller, right, discovered a specific type of immune cell associated with immune system overreaction in 2020 while treating COVID-19 patients. The work recently was funded by $5.8 in NIH grants.
UofL receives $11.5 million to advance cancer immunotherapies Center for Cancer Immunology and Immunotherapy to develop and improve cancer treatments that harness the immune system
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other...
UofL's contact tracing team
Public health students help keep campus safe, gain valuable skills as contact tracing specialists
They鈥檝e spent hours training, including the completion of Johns Hopkins University鈥檚 online contact tracing course. Now, nearly a dozen undergraduate and graduate students from...
Campus-wide testing is a critical piece of UofL's low positivity rate for COVID-19.
Student, faculty, staff cooperation are keys to early on-campus COVID prevention
The early grades on COVID testing are in, and the UofL community is doing its part to stay safe. Two weeks into the semester, UofL...
Immunomodulatory signal presentation via synthetic hydrogel material promotes generation of T regulatory cells (green) in the local graft microenvironment (CD3+ T cells in red, and nuclei staining in blue) after implantation into a clinically relevant transplant model for the treatment of type 1 diabetes. (Credit: Georgia Tech)
UofL-born technology for treating Type 1 diabetes has commercial partner
A University of Louisville-born therapy that helps people with Type 1 diabetes stay off immunosuppressants by re-educating the body鈥檚 immune system to accept transplanted...
PhD student Zach Whiddon
NIH funds UofL doctoral students鈥 work on taste buds and brain circuitry
You may be confident in your potential to pursue a career in biomedical research when the National Institutes of Health funds your work before...
UofL Trager Institute
UofL Trager Institute uses technology to reduce social isolation for older adults Initiatives to benefit older adults during pandemic to be discussed in weekly information session Aug. 4
Amid efforts to stem the spread of the COVID-19 pandemic, social isolation and loneliness have emerged as a significant public health crisis, particularly for...
Map 2: Prevalence of COVID-19 in Jefferson County in June 2020.
Phase II results of Co-Immunity Project show higher-than-expected rates of coronavirus exposure in Jefferson County
Results from the second phase of the University of Louisville鈥檚 groundbreaking project to track COVID-19 in Jefferson County show that 4 to 6 times...
Geoffrey Clark, Ph.D.
UofL technology that may inhibit pathway for cancer gets commercial partner Researchers say the technology could solve 鈥渙ne of the holy grails鈥 of cancer treatment
NA University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company focused on developing...
A clinical trial for Aviptadil (RLF-100) is underway at UofL for severe COVID-19 patients. Image courtesy NeuroRx.
UofL conducting clinical trial on drug for severe COVID-19 respiratory effects
The University of Louisville is conducting a clinical trial on a new treatment for critically ill COVID-19 patients meant to lessen some of the...